Challenges to antimicrobial stewardship in the countries of the arab league: Concerns of worsening resistance during the COVID-19 pandemic and proposed solutions

dc.contributor.authorRizk, Nesrine A.
dc.contributor.authorMoghnieh, Rima A.
dc.contributor.authorHaddad, Nisrine
dc.contributor.authorRebeiz, Marie Claire
dc.contributor.authorZeenny, Rony M.
dc.contributor.authorHindy, Joya Rita
dc.contributor.authorOrlando, Gabriella
dc.contributor.authorKanj, Souha S.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.departmentDivision of Infectious Diseases
dc.contributor.departmentPharmacy
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:43:23Z
dc.date.available2025-01-24T11:43:23Z
dc.date.issued2021
dc.description.abstractThe COVID-19 pandemic is expected to worsen the global problem of antimicrobial resistance (AMR). There is a heightened interest in understanding this effect and to develop antimicrobial stewardship (AMS) interventions accordingly to curb this threat. Our paper aims to evaluate the potential magnitude of COVID-19 on AMR and AMS with a focus on the countries of the Arab league, given the social, political, and economic environments. We also evaluate obstacles in applying the rational use of antibiotics, monitoring resistance trends in the midst of the pandemic, and evaluating the impact of the economic crisis in some countries. We aim to raise awareness about the potential effects of antibiotic overuse during the pandemic and to propose practical approaches to tackle this issue. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
dc.identifier.doihttps://doi.org/10.3390/antibiotics10111320
dc.identifier.eid2-s2.0-85118925529
dc.identifier.urihttp://hdl.handle.net/10938/30277
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofAntibiotics
dc.sourceScopus
dc.subjectAntimicrobial resistance
dc.subjectAntimicrobial stewardship
dc.subjectArab countries
dc.subjectCovid-19
dc.subjectAzithromycin
dc.subjectCarbapenem
dc.subjectCephalosporin
dc.subjectChloroquine
dc.subjectFavipiravir
dc.subjectGanciclovir
dc.subjectHydroxychloroquine
dc.subjectIvermectin
dc.subjectLopinavir plus ritonavir
dc.subjectTigecycline
dc.subjectVoriconazole
dc.subjectAntibiotic resistance
dc.subjectAwareness
dc.subjectCarbapenem resistance
dc.subjectCoronavirus disease 2019
dc.subjectDisease surveillance
dc.subjectEconomic crisis
dc.subjectHealth care cost
dc.subjectHospitalization
dc.subjectHuman
dc.subjectInfection control
dc.subjectMonitoring
dc.subjectMucormycosis
dc.subjectPandemic
dc.subjectReview
dc.subjectStaphylococcus aureus
dc.subjectStreptococcus pneumoniae
dc.titleChallenges to antimicrobial stewardship in the countries of the arab league: Concerns of worsening resistance during the COVID-19 pandemic and proposed solutions
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-5845.pdf
Size:
1.08 MB
Format:
Adobe Portable Document Format